Alleviant Medical

Alleviant Medical is a privately held medical device company based in Austin, Texas, founded in 2017. The company focuses on developing innovative minimally invasive therapies for heart failure, a significant public health issue affecting millions globally. With a team of approximately 38 employees, Alleviant Medical aims to improve the lives of patients suffering from this condition. The flagship product, the Alleviant System (ALV1), is an investigational interatrial shunt device designed to manage heart failure without leaving a permanent implant. It targets symptomatic heart failure patients who do not respond to optimal therapies. The device has received Breakthrough Device Designation from the U.S. FDA and is currently undergoing evaluation in two pivotal clinical trials: the ALLAY-HF trial and the ALLAY-HFrEF trial, taking place in multiple countries. Alleviant Medical has secured substantial funding to support its development efforts and reported annual revenue of $9.5 million. The leadership team brings extensive industry experience, guiding the company in its mission to address heart failure treatment needs.